Complexity of bidirectional transcription and alternative splicing at human RCAN3 locus

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Facchin, Federica ^a   Vitale, Lorenza ^a   Bianconi, Eva ^a   Piva, Francesco ^b   Frabetti, Flavia ^a   Strippoli, Pierluigi ^a   Casadei, Raffaella ^a   Pelleri, Maria Chiara ^a   Piovesan, Allison ^a   Canaider, Silvia ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN; COMPLEMENTARY DNA; ISOPROTEIN; MESSENGER RNA; REGULATOR OF CALCINEURIN 3; UNCLASSIFIED DRUG; RCAN3 PROTEIN, HUMAN; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

5' UNTRANSLATED REGION; ADULT; ALTERNATIVE RNA SPLICING; ARTICLE; BIOINFORMATICS; COMPUTER MODEL; CONTROLLED STUDY; EXON; FEMALE; GENE; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENE LOCUS; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; HUMAN; HUMAN GENETICS; HUMAN TISSUE; IN VIVO STUDY; MALE; MULTIGENE FAMILY; NUCLEOTIDE SEQUENCE; PROMOTER REGION; RCAN3 GENE; SEQUENCE ANALYSIS; SPECIES DIFFERENTIATION; UNINDEXED SEQUENCE; AMINO ACID SEQUENCE; CPG ISLAND; GENE EXPRESSION PROFILING; GENETICS; MOLECULAR GENETICS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; BASE SEQUENCE; CPG ISLANDS; EXONS; GENE EXPRESSION PROFILING; HUMANS; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS, GENETIC; PROTEIN ISOFORMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY, AMINO ACID; SEQUENCE HOMOLOGY, NUCLEIC ACID; TRANSCRIPTION, GENETIC;

EID: 80053088886     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0024508     Document Type: Article

References (57)

1. Fuentes JJ, Pritchard MA, Planas AM, Bosch A, Ferrer I, et al. (1995) A new human gene from the Down syndrome critical region encodes a proline-rich protein highly expressed in fetal brain and heart. Hum Mol Genet 4: 1935-1944.
2. Miyazaki T, Kanou Y, Murata Y, Ohmori S, Niwa T, et al. (1996) Molecular cloning of a novel thyroid hormone-responsive gene, ZAKI-4, in human skin fibroblasts. J Biol Chem 271: 14567-14571.
3. Strippoli P, Lenzi L, Petrini M, Carinci P, Zannotti M, (2000) A new gene family including DSCR1 (Down Syndrome Candidate Region 1) and ZAKI-4: characterization from yeast to human and identification of DSCR1-like 2, a novel human member (DSCR1L2). Genomics 64: 252-263.
4. Davies KJ, Ermak G, Rothermel BA, Pritchard M, Heitman J, et al. (2007) Renaming the DSCR1/Adapt78 gene family as RCAN: regulators of calcineurin. FASEB J 21: 3023-3028.
5. Fuentes JJ, Genesca L, Kingsbury TJ, Cunningham KW, Perez-Riba M, et al. (2000) DSCR1, overexpressed in Down syndrome, is an inhibitor of calcineurin-mediated signaling pathways. Hum Mol Genet 9: 1681-1690.
6. Rothermel B, Vega RB, Yang J, Wu H, Bassel-Duby R, et al. (2000) A protein encoded within the Down syndrome critical region is enriched in striated muscles and inhibits calcineurin signaling. J Biol Chem 275: 8719-8725.
7. Mulero MC, Aubareda A, Schluter A, Perez-Riba M, (2007) RCAN3, a novel calcineurin inhibitor that down-regulates NFAT-dependent cytokine gene expression. Biochim Biophys Acta 1773: 330-341.
8. Aubareda A, Mulero MC, Perez-Riba M, (2006) Functional characterization of the calcipressin 1 motif that suppresses calcineurin-mediated NFAT-dependent cytokine gene expression in human T cells. Cell Signal 18: 1430-1438.
9. Bueno OF, Lips DJ, Kaiser RA, Wilkins BJ, Dai YS, et al. (2004) Calcineurin Abeta gene targeting predisposes the myocardium to acute ischemia-induced apoptosis and dysfunction. Circ Res 94: 91-99.
10. Molkentin JD, Lu JR, Antos CL, Markham B, Richardson J, et al. (1998) A calcineurin- dependent transcriptional pathway for cardiac hypertrophy. Cell 93: 215-228.
11. Aramburu J, Rao A, Klee CB, (2000) Calcineurin: from structure to function. Curr Top Cell Regul 36: 237-295.
12. Winslow MM, Neilson JR, Crabtree GR, (2003) Calcium signalling in lymphocytes. Curr Opin Immunol 15: 299-307.
13. Chin ER, Olson EN, Richardson JA, Yang Q, Humphries C, et al. (1998) A calcineurin- dependent transcriptional pathway controls skeletal muscle fiber type. Genes Dev 12: 2499-2509.
14. Parsons SA, Millay DP, Wilkins BJ, Bueno OF, Tsika GL, et al. (2004) Genetic loss of calcineurin blocks mechanical overload-induced skeletal muscle fiber type switching but not hypertrophy. J Biol Chem 279: 26192-26200.
15. Zeng H, Chattarji S, Barbarosie M, Rondi-Reig L, Philpot BD, et al. (2001) Forebrain-specific calcineurin knockout selectively impairs bidirectional synaptic plasticity and working/episodic- like memory. Cell 107: 617-629.
16. Lee JI, Ahnn J, (2004) Calcineurin in animal behavior. Mol Cells 17: 390-396.
17. Kim YS, Lee HJ, Jang C, Kim HS, Cho YJ, (2009) Knockdown of RCAN1.4 Increases Susceptibility to FAS-mediated and DNA-damage-induced Apoptosis by Upregulation of p53 Expression. Korean J Physiol Pharmacol 13: 483-489.
18. Sales KJ, Grant V, Cook IH, Maldonado-Perez D, Anderson RA, et al. (2010) Interleukin-11 in endometrial adenocarcinoma is regulated by prostaglandin F2alpha-F-prostanoid receptor interaction via the calcium-calcineurin-nuclear factor of activated T cells pathway and negatively regulated by the regulator of calcineurin-1. Am J Pathol 176: 435-445.
19. Canaider S, Vettraino M, Norling LV, Spisni E, Facchin F, et al. (2010) Human RCAN3 gene expression and cell growth in endothelial cells. Int J Mol Med 26: 913-918.
20. Canaider S, Facchin F, Griffoni C, Casadei R, Vitale L, et al. (2006) Proteins encoded by human Down syndrome critical region gene 1-like 2 (DSCR1L2) mRNA and by a novel DSCR1L2 mRNA isoform interact with cardiac troponin I (TNNI3). Gene 372: 128-136.
21. Cummins P, Perry SV, (1978) Troponin I from human skeletal and cardiac muscles. Biochem J 171: 251-259.
22. Facchin F, Canaider S, Vitale L, Frabetti F, Griffoni C, et al. (2008) Identification and analysis of human RCAN3 (DSCR1L2) mRNA and protein isoforms. Gene 407: 159-168.
23. Strippoli P, D'Addabbo P, Lenzi L, Giannone S, Canaider S, et al. (2002) Segmental paralogy in the human genome: a large-scale triplication on 1p, 6p, and 21q. Mamm Genome 13: 456-462.
24. Strausberg RL, Feingold EA, Grouse LH, Derge JG, Klausner RD, et al. (2002) Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. Proc Natl Acad Sci USA 99: 16899-16903.
25. Engels WR, (1993) Contributing software to the internet: the Amplify program. Trends Biochem Sci 18: 448-450.
26. Sharrocks AD, (1994) The design of primer for PCR. In: Griffin HG, Griffin AM, editors. PCR Technology- Current Innovations Boca Raton CRC Press pp. 5-11.
27. Davis LG, Kuehl WM, Battey JF, (1994) Basic Methods in Molecular Biology. Norwalk Appleton & Lange.
28. NCBI (National Center for Biotechnology Information) homepage Available: http://www.ncbi.nlm.nih.gov/, last accessed on 15/09/2010.
29. Kim N, Shin S, Lee S, (2005) ECgene: genome-based EST clustering and gene modeling for alternative splicing. Genome Res 15: 566-576.
30. Hinrichs AS, Karolchik D, Baertsch R, Barber GP, Bejerano G, et al. (2006) The UCSC Genome Browser Database: update 2006. Nucleic Acids Res 34: D590-598.
31. ClustalW homepage Available: http://www.ebi.ac.uk/clustalw, last accessed on 10/10/2010.
32. Hiller M, Nikolajewa S, Huse K, Szafranski K, Rosenstiel P, et al. (2007) TassDB: a database of alternative tandem splice sites. Nucleic Acids Res 35: D188-192.
33. Neural Network Promoter Prediction version 2.2 at Berkeley Drosophila Genome Project homepage Available: http://www.fruitfly.org/seq_tools/promoter.html, last accessed on 10/10/2010.
34. Neural Network Promoter Prediction Server at BIOSINO (Bioinformation Center of Shanghai Institutes for Biological Science Chinese Academy of Sciences) homepage Avaiable: http://Promoter.biosino.org, last accessed on 10/10/2010.
35. Davuluri RV, Grosse I, Zhang MQ, (2001) Computational identification of promoters and first exons in the human genome. Nat Genet 29: 412-417.
36. GenBank at NCBI homepage Available: http://www.ncbi.nlm.nih.gov/Genbank, last accessed on 15/09/2010.
37. Mader RM, Schmidt WM, Sedivy R, Rizovski B, Braun J, et al. (2001) Reverse transcriptase template switching during reverse transcriptase-polymerase chain reaction: artificial generation of deletions in ribonucleotide reductase mRNA. J Lab Clin Med 137: 422-428.
38. Hiller M, Platzer M, (2008) Widespread and subtle: alternative splicing at short-distance tandem sites. Trends Genet 24: 246-255.
39. Single Nucleotide Polymorphism Database homepage Available: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=snp, last accessed on 15/09/2010.
40. Lipps HJ, Rhodes D, (2009) G-quadruplex structures: in vivo evidence and function. Trends Cell Biol 19: 414-422.
41. Huppert JL, Balasubramanian S, (2007) G-quadruplexes in promoters throughout the human genome. Nucleic Acids Res 35: 406-413.
42. Chatterjee S, Pal JK, (2009) Role of 5′- and 3′-untranslated regions of mRNAs in human diseases. Biol Cell 101: 251-262.
43. Strippoli P, (2009) Analisi del genoma umano. In: Fantoni A, Bozzaro S, Del Sal G, Ferrari S, Tripodi M, editors. Biologia cellulare e genetica Parte Seconda Genetica. Padova Piccin Nuova Libreria S.p.A.
44. Casadei R, Strippoli P, D'Addabbo P, Canaider S, Lenzi L, et al. (2003) mRNA 5′ region sequence incompleteness: a potential source of systematic errors in translation initiation codon assignment in human mRNAs. Gene 321: 185-193.
45. Fuentes JJ, Pritchard MA, Estivill X, (1997) Genomic organization, alternative splicing, and expression patterns of the DSCR1 (Down syndrome candidate region 1) gene. Genomics 44: 358-361.
46. Genesca L, Aubareda A, Fuentes JJ, Estivill X, De La Luna S, et al. (2003) Phosphorylation of calcipressin 1 increases its ability to inhibit calcineurin and decreases calcipressin half-life. Biochem J 374: 567-575.
47. Cao X, Kambe F, Miyazaki T, Sarkar D, Ohmori S, et al. (2002) Novel human ZAKI-4 I soforms: hormonal and tissue-specific regulation and function as calcineurin inhibitors. Biochem J 367: 459-466.
48. Carninci P, Yasuda J, Hayashizaki Y, (2008) Multifaceted mammalian transcriptome. Curr Opin Cell Biol 20: 274-280.
49. Kim H, Klein R, Majewski J, Ott J, (2004) Estimating rates of alternative splicing in mammals and invertebrates. Nat Genet 36: 915-916 author reply 916-917.
50. Vitale L, Lenzi L, Huntsman SA, Canaider S, Frabetti F, et al. (2006) Differential expression of alternatively spliced mRNA forms of the insulin-like growth factor 1 receptor in human neuroendocrine tumors. Oncol Rep 15: 1249-1256.
51. Vitale L, Frabetti F, Huntsman SA, Canaider S, Casadei R, et al. (2007) Sequence, "subtle" alternative splicing and expression of the CYYR1 (cysteine/tyrosine-rich 1) mRNA in human neuroendocrine tumors. BMC Cancer 7: 66.
52. Blencowe BJ, (2006) Alternative splicing: new insights from global analyses. Cell 126: 37-47.
53. Riva A, Kohane IS, (2004) A SNP-centric database for the investigation of the human genome. BMC Bioinformatics 5: 33.
54. Baek D, Davis C, Ewing B, Gordon D, Green P, (2007) Characterization and predictive discovery of evolutionarily conserved mammalian alternative promoters. Genome Res 17: 145-155.
55. Davuluri RV, Suzuki Y, Sugano S, Plass C, Huang TH, (2008) The functional consequences of alternative promoter use in mammalian genomes. Trends Genet 24: 167-177.
56. Larsen F, Gundersen G, Lopez R, Prydz H, (1992) CpG islands as gene markers in the human genome. Genomics 13: 1095-1107.
57. Zhu J, He F, Hu S, Yu J, (2008) On the nature of human housekeeping genes. Trends Genet 24: 481-484.